PEAK6 Group’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,731
Closed -$101K 5410
2016
Q4
$101K Sell
5,731
-5,545
-49% -$119K ﹤0.01% 3868
2016
Q3
$263K Buy
+11,276
New +$256K ﹤0.01% 2926
2016
Q2
Sell
-9,208
Closed -$167K 5085
2016
Q1
$167K Sell
9,208
-10,103
-52% -$163K ﹤0.01% 3282
2015
Q4
$407K Buy
19,311
+357
+2% +$6.88K ﹤0.01% 2798
2015
Q3
$350K Buy
18,954
+12,990
+218% +$324K ﹤0.01% 3230
2015
Q2
$202K Buy
+5,964
New +$240K ﹤0.01% 3706
2015
Q1
Sell
-5,465
Closed -$248K 5529
2014
Q4
$121K Buy
+5,465
New +$126K ﹤0.01% 3722
2014
Q1
Sell
-396,130
Closed -$9.44M 5679
2013
Q4
$9.44M Buy
+396,130
New +$11.1M 0.07% 349

Other funds holding FMI

PEAK6 Group's FMI Position: Q1 2017 in Review

PEAK6 Group sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 5,731 shares — an estimated $101K sold.

PEAK6 Group first reported a position in FMI in Q4 2013 and held it in 8 quarters. The position peaked at $9.44M in Q4 2013. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

  • PEAK6 Group reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 5,731 Foundation Medicine, Inc. shares in Q1 2017, an estimated $101K.
  • PEAK6 Group first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 8 quarters.
  • PEAK6 Group's Foundation Medicine, Inc. position peaked at $9.44M in Q4 2013.
  • 93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.